| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 64483 |
|
2,887 |
2,628 |
$486K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,325 |
12,613 |
$455K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,702 |
6,734 |
$339K |
| 64484 |
|
1,739 |
1,592 |
$109K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,551 |
1,657 |
$85K |
| 64490 |
|
665 |
626 |
$56K |
| 64479 |
|
233 |
202 |
$36K |
| 20610 |
|
774 |
667 |
$21K |
| 64491 |
|
665 |
627 |
$20K |
| 96120 |
|
528 |
506 |
$19K |
| 64493 |
|
230 |
219 |
$17K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
205 |
196 |
$15K |
| 20550 |
|
644 |
523 |
$12K |
| 76942 |
|
185 |
178 |
$11K |
| 20551 |
|
343 |
313 |
$8K |
| 64494 |
|
228 |
217 |
$5K |
| 64480 |
|
33 |
33 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
160 |
137 |
$2K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,762 |
1,627 |
$2K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
777 |
601 |
$867.29 |
| 99442 |
|
276 |
231 |
$805.17 |
| 77002 |
|
29 |
24 |
$747.39 |
| 96103 |
|
372 |
365 |
$517.08 |
| 20552 |
|
17 |
16 |
$369.49 |
| 96102 |
|
160 |
144 |
$255.78 |
| 96136 |
|
281 |
108 |
$65.66 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
410 |
378 |
$8.20 |
| 77003 |
|
1,621 |
1,454 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
264 |
221 |
$0.00 |